CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.18 Billion EUR | 5.13% |
| 2022 | 1.12 Billion EUR | 10.18% |
| 2021 | 1.02 Billion EUR | 22.46% |
| 2020 | 837.25 Million EUR | 12.26% |
| 2019 | 745.8 Million EUR | 4.01% |
| 2018 | 717.02 Million EUR | 23.12% |
| 2017 | 582.37 Million EUR | 3.96% |
| 2016 | 560.19 Million EUR | 3.15% |
| 2015 | 543.06 Million EUR | 5.43% |
| 2014 | 515.1 Million EUR | 12.09% |
| 2013 | 459.55 Million EUR | 1.99% |
| 2012 | 450.58 Million EUR | 13.62% |
| 2011 | 396.56 Million EUR | 24.17% |
| 2010 | 319.36 Million EUR | 6.35% |
| 2009 | 300.28 Million EUR | 31.02% |
| 2008 | 229.19 Million EUR | 27.19% |
| 2007 | 180.18 Million EUR | 2978.73% |
| 2006 | 5.85 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 284.62 Million EUR | -7.27% |
| 2024 Q2 | 277.22 Million EUR | -2.6% |
| 2023 Q1 | 290.84 Million EUR | -11.24% |
| 2023 FY | 1.18 Billion EUR | 5.13% |
| 2023 Q4 | 306.92 Million EUR | 7.42% |
| 2023 Q3 | 285.71 Million EUR | -6.07% |
| 2023 Q2 | 304.17 Million EUR | 4.59% |
| 2022 Q2 | 265.04 Million EUR | 5.32% |
| 2022 Q3 | 285.38 Million EUR | 7.67% |
| 2022 Q1 | 251.64 Million EUR | -9.87% |
| 2022 FY | 1.12 Billion EUR | 10.18% |
| 2022 Q4 | 327.65 Million EUR | 14.81% |
| 2021 Q2 | 240.82 Million EUR | 5.19% |
| 2021 Q3 | 276.34 Million EUR | 14.75% |
| 2021 Q4 | 279.21 Million EUR | 1.04% |
| 2021 FY | 1.02 Billion EUR | 22.46% |
| 2021 Q1 | 228.93 Million EUR | -5.75% |
| 2020 FY | 837.25 Million EUR | 12.26% |
| 2020 Q4 | 242.91 Million EUR | 5.01% |
| 2020 Q3 | 231.32 Million EUR | 28.6% |
| 2020 Q2 | 179.88 Million EUR | -1.78% |
| 2020 Q1 | 183.14 Million EUR | -11.13% |
| 2019 Q1 | 175.21 Million EUR | -10.04% |
| 2019 Q3 | 177.91 Million EUR | -4.65% |
| 2019 Q4 | 206.08 Million EUR | 15.83% |
| 2019 Q2 | 186.59 Million EUR | 6.49% |
| 2019 FY | 745.8 Million EUR | 4.01% |
| 2018 Q1 | 165.96 Million EUR | 1.47% |
| 2018 Q4 | 194.77 Million EUR | 17.5% |
| 2018 Q3 | 165.76 Million EUR | -13.0% |
| 2018 Q2 | 190.52 Million EUR | 14.8% |
| 2018 FY | 717.02 Million EUR | 23.12% |
| 2017 Q2 | 139.54 Million EUR | -1.39% |
| 2017 FY | 582.37 Million EUR | 3.96% |
| 2017 Q4 | 163.55 Million EUR | 18.71% |
| 2017 Q3 | 137.77 Million EUR | -1.27% |
| 2017 Q1 | 141.5 Million EUR | -7.93% |
| 2016 Q2 | 135.55 Million EUR | 0.26% |
| 2016 Q4 | 153.68 Million EUR | 13.22% |
| 2016 FY | 560.19 Million EUR | 3.15% |
| 2016 Q3 | 135.73 Million EUR | 0.13% |
| 2016 Q1 | 135.2 Million EUR | -7.93% |
| 2015 Q2 | 138.14 Million EUR | 4.39% |
| 2015 Q3 | 125.73 Million EUR | -8.98% |
| 2015 FY | 543.06 Million EUR | 5.43% |
| 2015 Q1 | 132.33 Million EUR | -6.05% |
| 2015 Q4 | 146.84 Million EUR | 16.79% |
| 2014 Q1 | 122.06 Million EUR | -2.41% |
| 2014 Q4 | 140.85 Million EUR | 11.94% |
| 2014 FY | 515.1 Million EUR | 12.09% |
| 2014 Q2 | 126.34 Million EUR | 3.5% |
| 2014 Q3 | 125.83 Million EUR | -0.4% |
| 2013 FY | 459.55 Million EUR | 1.99% |
| 2013 Q4 | 125.07 Million EUR | 12.24% |
| 2013 Q1 | 113.51 Million EUR | -22.78% |
| 2013 Q3 | 111.43 Million EUR | 1.75% |
| 2013 Q2 | 109.51 Million EUR | -3.52% |
| 2012 Q2 | 111.29 Million EUR | -2.11% |
| 2012 Q1 | 113.69 Million EUR | -1.3% |
| 2012 Q3 | 107.03 Million EUR | -3.83% |
| 2012 Q4 | 147 Million EUR | 37.33% |
| 2012 FY | 450.58 Million EUR | 13.62% |
| 2011 Q2 | 89.14 Million EUR | -3.06% |
| 2011 Q4 | 115.19 Million EUR | 11.55% |
| 2011 FY | 396.56 Million EUR | 24.17% |
| 2011 Q3 | 103.26 Million EUR | 15.85% |
| 2011 Q1 | 91.95 Million EUR | -0.95% |
| 2010 Q2 | 78.2 Million EUR | 10.44% |
| 2010 FY | 319.36 Million EUR | 6.35% |
| 2010 Q1 | 70.8 Million EUR | -17.2% |
| 2010 Q4 | 92.84 Million EUR | 19.77% |
| 2010 Q3 | 77.51 Million EUR | -0.87% |
| 2009 Q3 | 71.96 Million EUR | -6.13% |
| 2009 FY | 300.28 Million EUR | 31.02% |
| 2009 Q1 | 66.15 Million EUR | 0.0% |
| 2009 Q4 | 85.51 Million EUR | 18.82% |
| 2009 Q2 | 76.66 Million EUR | 15.88% |
| 2008 FY | 229.19 Million EUR | 27.19% |
| 2007 FY | 180.18 Million EUR | 2978.73% |
| 2006 FY | 5.85 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DocCheck AG | 53.41 Million EUR | -2123.476% |
| MeVis Medical Solutions AG | 17.34 Million EUR | -6748.498% |
| Nexus AG | 241.45 Million EUR | -391.869% |